Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Pulse Biosciences, Inc.
pulsebiosciences.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pulse Biosciences awarded Chief Technology Officer Darrin R. Uecker 100,000 restricted stock units vesting over three years, recognizing his leadership in atrial fibrillation product development and signaling the company's commitment to retaining key technical talent.
Key Takeaways
CTO Darrin R. Uecker received 100,000 RSUs with a three-year vesting schedule, indicating confidence in his continued leadership
The award recognizes specific contributions to atrial fibrillation product development, a key therapeutic focus for the company
2 more takeaways
Related Filings (9)
9 more filings from Pulse Biosciences, Inc. in the last 90 days